X

Vous n'êtes pas connecté

  - WN.COM - Science - 25/Jun 17:53

Anti-insomnia drug approved

CHINESE drug regulatory authorities have approved a new anti-insomnia medication, according to Chinese media reports. Simcere Pharmaceutical Group Ltd., a Hong Kong-listed company headquartered in Nanjing, Jiangsu Province, announced that the National Medical Products Administration has approved Quviviq for the...

Articles similaires

Sorry! Image not available at this time

Anti-insomnia drug approved

wn.com - 25/Jun 17:53

CHINESE drug regulatory authorities have approved a new anti-insomnia medication, according to Chinese media reports. Simcere Pharmaceutical Group...

Sorry! Image not available at this time

Stablecoin: global dominance of the dollar and the Chinese challenge

cryptonomist.ch - 04/Jul 13:01

Hong Kong as a regulatory laboratory for Bitcoin and stablecoin

MV XIN HONG ZHUAN embarks on Cultural Exhibition Voyage Tributing Maritime Silk

cyprusshippingnews.com - 26/Jun 03:26

620 years ago, the renowned Chinese navigator Admiral ZHENG He commanded the world’s then most advanced wooden fleet, setting sail from...

MV XIN HONG ZHUAN embarks on Cultural Exhibition Voyage Tributing Maritime Silk

cyprusshippingnews.com - 26/Jun 03:26

620 years ago, the renowned Chinese navigator Admiral ZHENG He commanded the world’s then most advanced wooden fleet, setting sail from...

Sorry! Image not available at this time

NeuralFin adds strategic investors, DLH accelerates AI Agent push

surgezirc.co.za - 25/Jun 13:02

HONG KONG SAR – Media OutReach Newswire – 04 April 2025 – DL Holdings Group, a company listed on the Hong Kong Stock Exchange Main Board (stock...

Sorry! Image not available at this time

NeuralFin adds strategic investors, DLH accelerates AI Agent push

surgezirc.co.za - 25/Jun 13:02

HONG KONG SAR – Media OutReach Newswire – 04 April 2025 – DL Holdings Group, a company listed on the Hong Kong Stock Exchange Main Board (stock...

Sorry! Image not available at this time

FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

drugs.com - 02/Jul 00:07

July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and...

Sorry! Image not available at this time

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

wn.com - 06/Jul 12:34

US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are...

Sorry! Image not available at this time

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

wn.com - 06/Jul 12:34

US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are...

Sorry! Image not available at this time

Alibaba Group Announces Proposed Offering of Approximately HK$12 Billion of Zero Coupon Exchangeable Bonds

mangaloremirror.com - 03/Jul 10:41

HONG KONG–(BUSINESS WIRE)–Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba,”...